Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) just unveiled an announcement.
On May 5, 2026, Guardian Pharmacy Services, Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected Class II directors John Ackerman and Randall Lewis to the board to serve until the 2029 annual meeting and the election of their successors. Stockholders also approved, on a non-binding basis, the compensation of the company’s named executive officers and supported a one-year frequency for future advisory votes on executive pay, solidifying annual say-on-pay votes as part of the company’s governance framework.
In addition, shareholders ratified the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for 2026, reinforcing continuity in external financial oversight. The outcomes of these votes collectively affirmed management’s recommendations and indicate broad investor support for the company’s current leadership, compensation practices, and audit arrangements.
The most recent analyst rating on (GRDN) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Guardian Pharmacy Services, Inc. Class A stock, see the GRDN Stock Forecast page.
Spark’s Take on GRDN Stock
According to Spark, TipRanks’ AI Analyst, GRDN is a Outperform.
The score is driven primarily by strengthening fundamentals (notably improved balance sheet and strong cash generation) and supportive technical uptrend. These positives are tempered by premium valuation (P/E ~38) and the key fundamental risk of earnings volatility, while the latest earnings call adds confidence via raised 2026 EBITDA guidance despite acknowledged policy and margin headwinds.
To see Spark’s full report on GRDN stock, click here.
More about Guardian Pharmacy Services, Inc. Class A
Guardian Pharmacy Services, Inc. operates in the healthcare and pharmaceutical services sector, providing pharmacy-related services to its customers and operating under a corporate governance structure overseen by a board of directors and independent auditors. The company is publicly held, with key decisions and oversight matters subject to annual stockholder approval at its formal meetings.
Average Trading Volume: 416,235
Technical Sentiment Signal: Buy
Current Market Cap: $2.32B
For an in-depth examination of GRDN stock, go to TipRanks’ Overview page.